Programs · Research

Open science, student-led.

Research at NHA is student-led and public: mentored projects on neurodegeneration and neurodivergence, plus free tools that put the science in anyone's hands.

Featured poster

Does exam format decide who succeeds?

Presented at HOSA's State Leadership Conference, this study asks whether a test's format, more than its content, quietly disadvantages neurodivergent students.

Research poster: Exam Question Format as a Determinant of Performance Equity Among Neurodivergent High School Students, by Suhani Gupta, HOSA SLC 2026
Exam Question Format as a Determinant of Performance Equity Among Neurodivergent High School Students · HOSA SLC 2026. Open the full poster (PDF) ↗
Tracks

What we study.

Track 01

Alzheimer's & protein misfolding

Mapping the misfolding behind neurodegeneration, made explorable through our open tool, OpenConforma.

OpenConforma ↗
Track 02

Neurodivergence & attention

Behavioral, game-based measurement of attention, and what it means for accessible ADHD screening.

A(rDx)HD ↗
Track 03

Access & screening

How to shrink the cost, wait, and stigma between a young person and a first step toward help.

Scoreless ↗
Out in the field

Where we share the work.

Students present NHA research at symposia and conferences, from local science fairs to international stages.

Suhani Gupta presenting the A(rDx)HD screening project at a research conference

Conference floor

Presenting the A(rDx)HD screening work

fMRI eigenvector-centrality figures comparing ADHD and neurotypical brains

The data

fMRI: ADHD vs. neurotypical connectivity

Suhani Gupta at the Junior Science and Humanities Symposium

JSHS

Junior Science & Humanities Symposium

Featured project

The work itself.

Mentored student work, presented at HOSA and BioTech Futures.

NeuroengineeringHOSA · BioTech Futures

Targeted Alzheimer's therapy

Student researchers: Suhani Gupta & Ronav Gupta

Alzheimer's is driven by several processes at once, and today's antibody treatments address only part of that picture while requiring ongoing infusions. This project explores a more targeted, gene-based approach meant to act where the disease is active, developed and presented as a student research concept at HOSA and BioTech Futures.

Context, 2026

7M+ Americans live with Alzheimer's; in May 2025 the FDA cleared the first blood test to help diagnose it, and AlphaFold's protein-structure work won the 2024 Nobel Prize in Chemistry. (Alzheimer's Association 2025; FDA 2025. Research context, not medical advice.)

For students

Research with us.

Chapters get access to mentored research opportunities, a rare chance to contribute to published work while you're still in school.

Note

Our tools are research and education, not medical advice or diagnosis. Predictions and screenings are a starting point to discuss with a professional.